A long-term prognosis study of human USP8-mutated ACTH-secreting pituitary neuroendocrine tumours
- PMID: 38691659
- DOI: 10.1111/cen.15065
A long-term prognosis study of human USP8-mutated ACTH-secreting pituitary neuroendocrine tumours
Abstract
Objective: Somatic variants in the ubiquitin-specific protease 8 (USP8) gene are the most common genetic cause of Cushing disease. We aimed to explore the relationship between clinical outcomes and USP8 status in a single centre.
Design, patients and measurements: We investigated the USP8 status in 48 patients with pituitary corticotroph tumours. A median of 62 months of follow-up was conducted after surgery from November 2013 to January 2015. The clinical, biochemical and imaging features were collected and analysed.
Results: Seven USP8 variants (p.Ser718Pro, p.Ser719del, p.Pro720Arg, p.Pro720Gln, p.Ser718del, p.Ser718Phe, p.Lys713Arg) were identified in 24 patients (50%). USP8 variants showed a female predominance (100% vs. 75% in wild type [WT], p = .022). Patients with p.Ser719del showed an older age at surgery compared to patients with the p.Pro720Arg variant (47- vs. 24-year-olds, p = .033). Patients with p.Pro720Arg showed a higher rate of macroadenoma compared to patients harbouring the p.Ser718Pro variant (60% vs. 0%, p = .037). No significant differences were observed in serum and urinary cortisol and adrenocorticotropin hormone (ACTH) levels. Immediate surgical remission (79% vs. 75%) and long-term hormone remission (79% vs. 67%) were not significantly different between the two groups. The recurrence rate was 21% (4/19) in patients harbouring USP8 variants and 13% (2/16) in WT patients. Recurrence-free survival presented a tendency to be shorter in USP8-mutated individuals (76.7 vs. 109.2 months, p = .068).
Conclusions: Somatic USP8 variants accounted for 50% of the genetic causes in this cohort with a significant female frequency. A long-term follow-up revealed a tendency toward shorter recurrence-free survival in USP8-mutant patients.
Keywords: ACTH; Cushing's disease; USP8; recurrence; remission.
© 2024 John Wiley & Sons Ltd.
Similar articles
-
Clinical characteristics and surgical outcome in USP8-mutated human adrenocorticotropic hormone-secreting pituitary adenomas.Endocrine. 2019 Feb;63(2):240-246. doi: 10.1007/s12020-018-1776-0. Epub 2018 Oct 12. Endocrine. 2019. PMID: 30315484
-
Somatic USP8 Gene Mutations Are a Common Cause of Pediatric Cushing Disease.J Clin Endocrinol Metab. 2017 Aug 1;102(8):2836-2843. doi: 10.1210/jc.2017-00161. J Clin Endocrinol Metab. 2017. PMID: 28505279 Free PMC article.
-
Targeted analysis of Ubiquitin-Specific Peptidase (USP8) in a population of Iranian people with Cushing's disease and a systematic review of the literature.BMC Endocr Disord. 2024 Jun 11;24(1):86. doi: 10.1186/s12902-024-01619-z. BMC Endocr Disord. 2024. PMID: 38862897 Free PMC article.
-
Recurrent gain-of-function USP8 mutations in Cushing's disease.Cell Res. 2015 Mar;25(3):306-17. doi: 10.1038/cr.2015.20. Epub 2015 Feb 13. Cell Res. 2015. PMID: 25675982 Free PMC article.
-
Clinical Spectrum of USP8 Pathogenic Variants in Cushing's Disease.Arch Med Res. 2023 Dec;54(8):102899. doi: 10.1016/j.arcmed.2023.102899. Epub 2023 Nov 2. Arch Med Res. 2023. PMID: 37925320 Review.
Cited by
-
Real-World Experience with Pasireotide-LAR in Cushing's Disease: Single-Center 12-Month Observational Study.J Clin Med. 2025 Apr 18;14(8):2794. doi: 10.3390/jcm14082794. J Clin Med. 2025. PMID: 40283624 Free PMC article.
References
REFERENCES
-
- Hofmann BM, Hlavac M, Martinez R, Buchfelder M, Müller OA, Fahlbusch R. Long‐term results after microsurgery for Cushing disease: experience with 426 primary operations over 35 years. J Neurosurg. 2008;108(1):9‐18. doi:10.3171/jns/2008/108/01/0009
-
- Lacroix A, Feelders RA, Stratakis CA, Nieman LK. Cushing's syndrome. Lancet. 2015;386(9996):913‐927. doi:10.1016/s0140-6736(14)61375-1
-
- Sundaram NK, Carluccio A, Geer EB. Characterization of persistent and recurrent Cushing's disease. Pituitary. 2014;17(4):381‐391. doi:10.1007/s11102-013-0511-3
-
- Chen J, Jian X, Deng S, et al. Identification of recurrent USP48 and BRAF mutations in Cushing's disease. Nat Commun. 2018;9(1):3171. doi:10.1038/s41467-018-05275-5
-
- Ma ZY, Song ZJ, Chen JH, et al. Recurrent gain‐of‐function USP8 mutations in Cushing's disease. Cell Res. 2015;25(3):306‐317. doi:10.1038/cr.2015.20
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Molecular Biology Databases
Research Materials
Miscellaneous